Summary of Study ST002526

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001627. The data can be accessed directly via it's Project DOI: 10.21228/M8D434 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Study ID	ST002526
Study Title	Stable isotope tracing of 15N2-glutamine in orthotopic pancreatic ductal adenocarcinoma tumor bearing mice and non tumor-bearing controls
Study Summary	Stable isotope tracing by bolus intravenous injections of 15N2-glutamine in orthotopic PDAC tumor bearing mice and non tumor-bearing controls followed by plasma sampling and tumor extraction for analysis of intratumoral metabolite labeling during the period of kinetic labeling
Institute	University of Chicago
Last Name	Apiz Saab
First Name	Juan
Address	929 E. 57th St.
Email	japizsaab@uchicago.edu
Phone	7738346506
Submit Date	2022-08-05
Raw Data Available	Yes
Raw Data File Type(s)	raw(Thermo)
Analysis Type Detail	LC-MS
Release Date	2023-04-13
Release Version	1

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:	TR002638
Treatment Summary:	Orthotopic tumors were implanted in C57BL6J mice at 8-12 weeks of age. 4 weeks after induction tumor-bearing mice and healthy littermate controls were treated with 15N2-glutamine (Cambridge Isotope Laboratory #NLM-1328-PK) dissolved in sterile phosphate buffered saline at 7.2mg/animal by tail vein injection as previously described (Lane et al., 2015). Briefly, animals were dosed three times at 15-minute intervals.

Treatment ID:

TR002638

Treatment Summary:

Orthotopic tumors were implanted in C57BL6J mice at 8-12 weeks of age. 4 weeks after induction tumor-bearing mice and healthy littermate controls were treated with 15N2-glutamine (Cambridge Isotope Laboratory #NLM-1328-PK) dissolved in sterile phosphate buffered saline at 7.2mg/animal by tail vein injection as previously described (Lane et al., 2015). Briefly, animals were dosed three times at 15-minute intervals.